492 related articles for article (PubMed ID: 32668612)
1. Fundamental Mechanisms of Autoantibody-Induced Impairments on Ion Channels and Synapses in Immune-Mediated Cerebellar Ataxias.
Mitoma H; Honnorat J; Yamaguchi K; Manto M
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32668612
[TBL] [Abstract][Full Text] [Related]
2. Advances in the Pathogenesis of Auto-antibody-Induced Cerebellar Synaptopathies.
Mitoma H; Manto M
Cerebellum; 2023 Feb; 22(1):129-147. PubMed ID: 35064896
[TBL] [Abstract][Full Text] [Related]
3. Cerebellar long-term depression and auto-immune target of auto-antibodies: the concept of LTDpathies.
Mitoma H; Honnorat J; Yamaguchi K; Manto M
Mol Biomed; 2021 Jan; 2(1):2. PubMed ID: 35006439
[TBL] [Abstract][Full Text] [Related]
4. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
Levite M
J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
[TBL] [Abstract][Full Text] [Related]
5. [Immune-Mediated Cerebellar Ataxias].
Mitoma H
Brain Nerve; 2023 Jun; 75(6):737-747. PubMed ID: 37287357
[TBL] [Abstract][Full Text] [Related]
6. 'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 2: Anti-PKC-gamma, anti-GluR-delta2, anti-Ca/ARHGAP26 and anti-VGCC.
Jarius S; Wildemann B
J Neuroinflammation; 2015 Sep; 12():167. PubMed ID: 26377184
[TBL] [Abstract][Full Text] [Related]
7. Long-term clinical follow-up of a patient with non-paraneoplastic cerebellar ataxia associated with anti-mGluR1 autoantibodies.
Yoshikura N; Kimura A; Fukata M; Fukata Y; Yokoi N; Harada N; Hayashi Y; Inuzuka T; Shimohata T
J Neuroimmunol; 2018 Jun; 319():63-67. PubMed ID: 29685291
[TBL] [Abstract][Full Text] [Related]
8. Immune Ataxias: The Continuum of Latent Ataxia, Primary Ataxia and Clinical Ataxia.
Manto M; Mitoma H
J Integr Neurosci; 2024 Apr; 23(4):79. PubMed ID: 38682229
[TBL] [Abstract][Full Text] [Related]
9. Neuronal antibodies in nonparaneoplastic autoimmune cerebellar ataxias.
Saiz A; Graus F
Curr Opin Neurol; 2024 Jun; 37(3):322-328. PubMed ID: 38483149
[TBL] [Abstract][Full Text] [Related]
10. 'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook.
Jarius S; Wildemann B
J Neuroinflammation; 2015 Sep; 12():168. PubMed ID: 26377319
[TBL] [Abstract][Full Text] [Related]
11. [Immune-Mediated Cerebellar Ataxias].
Mitoma H
Brain Nerve; 2021 May; 73(5):611-619. PubMed ID: 34006695
[TBL] [Abstract][Full Text] [Related]
12. Responses to and Outcomes of Treatment of Autoimmune Cerebellar Ataxia in Adults.
Jones AL; Flanagan EP; Pittock SJ; Mandrekar JN; Eggers SD; Ahlskog JE; McKeon A
JAMA Neurol; 2015 Nov; 72(11):1304-12. PubMed ID: 26414229
[TBL] [Abstract][Full Text] [Related]
13. Neuronal central nervous system syndromes probably mediated by autoantibodies.
Chefdeville A; Honnorat J; Hampe CS; Desestret V
Eur J Neurosci; 2016 Jun; 43(12):1535-52. PubMed ID: 26918657
[TBL] [Abstract][Full Text] [Related]
14. mGluR1 signaling in cerebellar Purkinje cells: Subcellular organization and involvement in cerebellar function and disease.
Yamasaki M; Aiba A; Kano M; Watanabe M
Neuropharmacology; 2021 Aug; 194():108629. PubMed ID: 34089728
[TBL] [Abstract][Full Text] [Related]
15. Pathogenic Roles of Glutamic Acid Decarboxylase 65 Autoantibodies in Cerebellar Ataxias.
Mitoma H; Manto M; Hampe CS
J Immunol Res; 2017; 2017():2913297. PubMed ID: 28386570
[TBL] [Abstract][Full Text] [Related]
16. New autoantibody mediated disorders of the central nervous system.
Lang B; Dale RC; Vincent A
Curr Opin Neurol; 2003 Jun; 16(3):351-7. PubMed ID: 12858073
[TBL] [Abstract][Full Text] [Related]
17. Autoantibody-mediated disorders of the central nervous system.
Irani S; Lang B
Autoimmunity; 2008 Feb; 41(1):55-65. PubMed ID: 18176865
[TBL] [Abstract][Full Text] [Related]
18. Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis.
Bien CG; Vincent A; Barnett MH; Becker AJ; Blümcke I; Graus F; Jellinger KA; Reuss DE; Ribalta T; Schlegel J; Sutton I; Lassmann H; Bauer J
Brain; 2012 May; 135(Pt 5):1622-38. PubMed ID: 22539258
[TBL] [Abstract][Full Text] [Related]
19. Presynaptic impairment of cerebellar inhibitory synapses by an autoantibody to glutamate decarboxylase.
Mitoma H; Song SY; Ishida K; Yamakuni T; Kobayashi T; Mizusawa H
J Neurol Sci; 2000 Apr; 175(1):40-4. PubMed ID: 10785255
[TBL] [Abstract][Full Text] [Related]
20. Immunological Bases of Paraneoplastic Cerebellar Degeneration and Therapeutic Implications.
Yshii L; Bost C; Liblau R
Front Immunol; 2020; 11():991. PubMed ID: 32655545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
